General Information
Version
3.0 (replaces version 2.0
Revision date
2025-08-21
Product name
Batroxobin Concentrate
1.2.1 Relevant identified uses
API
Emergency telephone
+41 44 251 51 51, +41 44 251 66 66
Icons in SDS
Company Information
company name
Pentapharm AG
e-mail address of the competent person responsible for the Safety Data Sheet
pentapharm@pentapharm.com
GHS Information
Signal word
Void
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Hazard pictograms
Void
Signal word
Void
Hazard statements
Void
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
0.1 - 1% of the mixture consists of component(s) of unknown toxicity extracted from snake venom. Non-classification of the product is based on the calculation method. EUH208 Contains Batroxobin (glycoprotein, serine proteinase). May produce an allergic reaction. EUH210 Safety data sheet available on request.
PBT Substances
According to current knowledge, the product contains no PBT substance
vPvB Substances
According to current knowledge, the product contains no vPvB substance (Contd. of page 1) Determination of endocrine-disrupting properties Taking into account the current state of scientific knowledge, no data on endocrine disrupting properties of the product are available.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 The product is not classified, according to the CLP regulation.
